These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 37240138)

  • 1. Inflammation: The Link between Neural and Vascular Impairment in the Diabetic Retina and Therapeutic Implications.
    Ramos H; Hernández C; Simó R; Simó-Servat O
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy.
    Deliyanti D; Zhang Y; Khong F; Berka DR; Stapleton DI; Kelly DJ; Wilkinson-Berka JL
    PLoS One; 2015; 10(7):e0134392. PubMed ID: 26222724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy in the retinal neurovascular unit: New perspectives into diabetic retinopathy.
    Yang X; Huang Z; Xu M; Chen Y; Cao M; Yi G; Fu M
    J Diabetes; 2023 May; 15(5):382-396. PubMed ID: 36864557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SGLT2 Inhibitor-Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy-A Novel Hypothesis.
    Mudaliar S; Hupfeld C; Chao DL
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1235-1244. PubMed ID: 33512450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyroptosis in the Retinal Neurovascular Unit: New Insights Into Diabetic Retinopathy.
    Meng C; Gu C; He S; Su T; Lhamo T; Draga D; Qiu Q
    Front Immunol; 2021; 12():763092. PubMed ID: 34737754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of inflammation in diabetic eye disease.
    Mesquida M; Drawnel F; Fauser S
    Semin Immunopathol; 2019 Jul; 41(4):427-445. PubMed ID: 31175392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory mediators in diabetic retinopathy: Deriving clinicopathological correlations for potential targeted therapy.
    Sheemar A; Soni D; Takkar B; Basu S; Venkatesh P
    Indian J Ophthalmol; 2021 Nov; 69(11):3035-3049. PubMed ID: 34708739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitoylethanolamide treatment reduces retinal inflammation in streptozotocin-induced diabetic rats.
    Paterniti I; Di Paola R; Campolo M; Siracusa R; Cordaro M; Bruschetta G; Tremolada G; Maestroni A; Bandello F; Esposito E; Zerbini G; Cuzzocrea S
    Eur J Pharmacol; 2015 Dec; 769():313-23. PubMed ID: 26607470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-CNS connections: implications in the pathogenesis of diabetic retinopathy.
    Yellowlees Douglas J; Bhatwadekar AD; Li Calzi S; Shaw LC; Carnegie D; Caballero S; Li Q; Stitt AW; Raizada MK; Grant MB
    Prog Retin Eye Res; 2012 Sep; 31(5):481-94. PubMed ID: 22609081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
    Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
    Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurovascular regulation in diabetic retinopathy and emerging therapies.
    Ji L; Tian H; Webster KA; Li W
    Cell Mol Life Sci; 2021 Aug; 78(16):5977-5985. PubMed ID: 34230991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.
    Kern TS; Miller CM; Du Y; Zheng L; Mohr S; Ball SL; Kim M; Jamison JA; Bingaman DP
    Diabetes; 2007 Feb; 56(2):373-9. PubMed ID: 17259381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic Retinopathy: Pathophysiology and Treatments.
    Wang W; Lo ACY
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29925789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-150 (miR-150) and Diabetic Retinopathy: Is miR-150 Only a Biomarker or Does It Contribute to Disease Progression?
    Ko GY; Yu F; Bayless KJ; Ko ML
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of lipopolysaccharides in diabetic retinopathy.
    Qin X; Zou H
    BMC Ophthalmol; 2022 Feb; 22(1):86. PubMed ID: 35193549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Of neurons and pericytes: The neuro-vascular approach to diabetic retinopathy.
    Eleftheriou CG; Ivanova E; Sagdullaev BT
    Vis Neurosci; 2020 Aug; 37():E005. PubMed ID: 32778188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of microglia in the retina: new insights into diabetic retinopathy.
    Arroba AI; Valverde ÁM
    Acta Diabetol; 2017 Jun; 54(6):527-533. PubMed ID: 28349217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Inflammatory (M2) Response Is Induced by a sp
    Cano-Cano F; Alcalde-Estévez E; Gómez-Jaramillo L; Iturregui M; Sánchez-Fernández EM; García Fernández JM; Ortiz Mellet C; Campos-Caro A; López-Tinoco C; Aguilar-Diosdado M; Valverde ÁM; Arroba AI
    Front Immunol; 2021; 12():632132. PubMed ID: 33815384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy.
    Tang L; Xu GT; Zhang JF
    Neural Regen Res; 2023 May; 18(5):976-982. PubMed ID: 36254977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Fingerprint in Diabetes: Ocular Surface and Retinal Inflammation.
    Amorim M; Martins B; Fernandes R
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.